Sprint Bioscience is a pharmaceutical company focused on developing drugs to fight cancer. It runs pharmaceutical projects from conception to drug candidates ready for clinical trials. Sprint Bioscience's portfolio of projects is focused on exploiting metabolic pathways for the treatment of cancer. Additionally, the company develops a program for type 2 diabetes.